Managed Healthcare Executive December 17, 2024
Denise Myshko

A new bill in Congress would require pass-through prices in both Medicare, and Medicaid and require transparency of PBM practices in the commercial space.

Congress is working on an end-of-year package for funding the government through March 2025 that includes some changes for pharmacy benefit managers (PBMs) and group purchasing organizations. The proposed bill as currently written includes changes to Medicare and Medicare and includes some measures around transparency of PBM practices in the commercial space.

Patrick Cooney, president of the lobby group The Federal Group, said the big surprise is the changes that will impact the commercials plans.

“We’ve expected changes, but the new element is PBM reform,” he said in an interview. “Congress is also going to institute...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
MSD opens $1bn plant for HPV vaccine in the US
AI Superintelligence Startup Promises New Drug Discoveries
STAT+: Roche partners with Zealand Pharma to push forward obesity drug
Trends Shaping Direct to Patient in Pharma: Q&A with Scott Snyder
4 Prescription Drug Trends that are Top of Mind for One Abarca Exec

Share This Article